Immediate Implants: to Graft or Not to Graft, That is the Question.
NCT ID: NCT05927181
Last Updated: 2023-07-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
31 participants
INTERVENTIONAL
2009-04-30
2020-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Outcome and Complications Encountered in Flapless Surgery and Immediate Loading Versus the Classical Surgical Approach and Loading After 6-8 Weeks in the Posterior Maxilla
NCT00137150
State of the Art Immediate Implant Placement in the Premaxilla
NCT07080710
Timing of Soft Tissue Grafting Following Immediate Implant Placement
NCT05537545
Success of Implant Restorations After Immediate or Delayed Implant Placement With/Without Ridge Preservation
NCT05988281
Dental Autotransplantation or Immediate Single Implant for the Replacement of a Hopeless Molar.
NCT05669118
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patient population
Patients in need of single implant supported restorations in the anterior maxilla (canines, lateral and central incisors) were selected for this study. The indications for tooth extractions were cavities, endodontic complications (e.g., root fracture), internal resorption and prosthetic reasons. The patients had to fulfil the following inclusion and exclusion criteria:
Inclusion criteria:
* ≥18 years of age
* Need for tooth extraction in the anterior maxilla (13-23) due to cavities, internal resorption, fractures, restorative problems, endodontic complications and prosthetic reasons.
* The failing tooth has adjacent and opposing natural teeth
* Adequate oral hygiene (Bleeding on probing \<20%; Plaque index \<20%);
* Absence of active and uncontrolled periodontal disease
* Sufficient mesial-distal and interocclusal space for implant placement and definitive restoration
* Sufficient interocclusal space to design a non-occluding provisional restoration
Exclusion criteria:
* Systemic metabolic or osseous disease that could compromise peri-implant tissue healing
* Acute infection in the treatment area
* Absence of one or both adjacent teeth
* Non-integrity of the buccal bone wall (dehiscence or fenestration) observed during surgery, or when tooth extraction has altered the integrity of the osseous and gingival architecture
The participants were screened by two investigators (GC \& JGF) and comprised two consecutive study groups with the following interventions:
1. Flapless immediate implant placement and provisional restoration (trimodal approach: TA) (n=15).
2. Flapless immediate implant placement and provisional restoration with alveolar filling and connective tissue graft (trimodal approach with osseous and mucosal compartment modification: TAOM) (n=16).
Treatment protocol and follow-up
Four visits were intended to be delivered in each participant. Following the selection of candidates, study casts were prepared for all patients as well as preoperative photographs and parallel periapical radiographs of the problematic tooth. Rigid stents were prepared with light-cured resin, covering the incisal edges of at least one adjacent tooth on each side of the target tooth. Measurements from reference points to mid-buccal soft tissue height and mesial and distal papillae were recorded at T0. The stents were \> 2 mm thick so they could be modified to allow for a perfect fit over the final restoration.
All surgical procedures were performed by two experienced surgeons and investigators (GC\& JGF). Without raising a mucoperiosteal flap, a careful tooth extraction was performed, allowing for the preservation of soft and hard tissues. In 10 patients, the Benex Extractor® (Benex Root Extraction System, Hager and Meisinger GMbH, Neuss, Germany) was used to ensure atraumatic extraction. Then, a detailed examination of the buccal bone wall was carried out to verify its integrity. In the cases when the integrity of the bone wall was in question, the patient was excluded from the study and the implant was placed by means of conventional protocols.
Measurement of the total periodontal thickness (phenotype) was taken at this time by means of an analogic calliper located 5 mm apical to the buccal gingival margin, to locate the bundle bone level.
Then, the implant bed was prepared on the palatal side of the extraction socket in accordance with the manufacturer's instructions (Bone Level -BL- and Tissue Level -TL-, Straumann AG, Switzerland; Thoma et al., 2021). The implant was placed securing the ideal position at a depth of 2mm for the TL implant and 4mm for the BL implant and in a palatal position allowing for a direct screw-retained restoration (1-3 mm from the bone wall) for all implants. It was also verified that the wall of the post-extraction socket was not perforated during implant bed preparation. The implant had to show good primary stability in its ideal position, in order to avoid being excluded from the study. In the TA group, no material was used to fill the gap between the implant and the osseous wall and no soft tissue graft was attempted either. In the TAOM group, the gap between the implant and the facial bone wall was grafted with inorganic bovine bone (Geistlich Bio-Oss®; Geistlich Pharma AG, Wolhusen, Switzerland) and, in addition, a connective tissue graft (CTG) was harvested from the anterior palate region and placed submucosally on the labial bone plate by means of an envelope technique.
Following implant placement, an acrylic resin implant-supported provisional restoration was prepared, adapted and delivered for all implants. All provisional restorations were directly screw-retained and designed with no occlusal contacts, neither in maximum intercuspal position nor in excursive movements. The emergence profile was mainly flat or concave in interproximal and palatal sides, and slightly convex in the buccal aspect to support the soft tissues for the TA group. In the TAOM group, it was slightly concave to provide space for the soft-tissue graft and avoid isquemia in the marginal mucosa. Intra-oral radiographs were taken to check implant position and the fit of the restoration. Systemic antibiotics (Azitromicin-500mg/24h/3days) and anti-inflammatories (Dexketoprofen-25mg/8h/3days) were prescribed, together with a clorhexidine 0.20 % gel twice a day for one week. Patients were then recalled for a post-operative check-up and sutures were removed after 14 days.
At 3 months, final impressions were made. After abutment selection and bisque try-ins, final restorations were permanently placed at 4 months.
The tooth-supported acrylic resin measuring stent was then adapted to allow for a complete fit on the incisal edges of both neighbouring teeth, to ensure a reliable positioning and measurement reference.
The first measurement was at day 0 (Immediate implant placement and provisionalisation). Patient recall appointments for examinations and measurements took place at 3, 6 and 12 months. No activities were performed to increase compliance or adherence in the selected patients beyong compliance of a good clinical practice.
Outcome measures The primary outcome variable of this study was the vertical midfacial soft tissue change from baseline (before tooth extraction) to 12 months following implant placement.
The secondary outcome measures were mesial and distal papillae vertical changes, periodontal phenotype at implant site, and mechanical complications.
The clinical outcomes were measured as follows:
* Vertical soft tissue changes were calculated through the distance from reference measuring points on the stent to mesial (MP) and distal (DP) papillae, and gingival zenith (Z) of the implant restoration. Distances were measured by means of a precision digital calliper that can display measurements as small as tenths of a millimetre. Three dimples were marked in the stent, in approximately the vertical projection of papillae and zenith (Supplementary figure 1a). Measurements were taken before tooth extraction (baseline) T0 and at 3 (T3), 6 (T6) and 12 (T12) months following the intervention.
* Periodontal phenotype thickness was measured by means of an analogical calliper that was able to show tenths of a millimetre. It was located 5 mm apical to the buccal gingival margin immediately after tooth extraction.
* Mechanical complications were assessed and included: screw loosening, loss of retention, chipping of acrylic or porcelain complications.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Trimodal Approach with Osseous and Mucosal compartment modification: TAOM
Flapless immediate implant placement and provisional restoration with alveolar filling and connective tissue graft.
TAOM
In the TAOM group, the gap between the implant and the facial bone wall was grafted with inorganic bovine bone (Geistlich Bio-Oss®; Geistlich Pharma AG, Wolhusen, Switzerland) and, in addition, a connective tissue graft (CTG) was placed submucosally on the labial bone plate by means of an envelope technique.
Trimodal Approach: TA
Flapless immediate implant placement and provisional restoration.
TAOM
In the TAOM group, the gap between the implant and the facial bone wall was grafted with inorganic bovine bone (Geistlich Bio-Oss®; Geistlich Pharma AG, Wolhusen, Switzerland) and, in addition, a connective tissue graft (CTG) was placed submucosally on the labial bone plate by means of an envelope technique.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TAOM
In the TAOM group, the gap between the implant and the facial bone wall was grafted with inorganic bovine bone (Geistlich Bio-Oss®; Geistlich Pharma AG, Wolhusen, Switzerland) and, in addition, a connective tissue graft (CTG) was placed submucosally on the labial bone plate by means of an envelope technique.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The failing tooth has adjacent and opposing natural teeth
* Adequate oral hygiene (Bleeding on probing \<20%; Plaque index \<20%);
* Absence of active and uncontrolled periodontal disease
* Sufficient mesial-distal and interocclusal space for implant placement and definitive restoration
* Sufficient interocclusal space to design a non-occluding provisional restoration
Exclusion Criteria
* Acute infection in the treatment area
* Absence of one or both adjacent teeth
* Non-integrity of the buccal bone wall (dehiscence or fenestration) observed during surgery, or when tooth extraction has altered the integrity of the osseous and gingival architecture
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Complutense de Madrid
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gustavo G Cabello
Role: PRINCIPAL_INVESTIGATOR
Private Practice, Málaga, Spain
Javier J Fabrega
Role: PRINCIPAL_INVESTIGATOR
Private Practice, Madrid, Spain
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maria Del Rosario Rioboo Crespo
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TMA-USE-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.